About: Chlorproguanil/dapsone

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, which act synergystically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency.

Property Value
dbo:abstract
  • Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, which act synergystically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency. (en)
dbo:casNumber
  • 209665-78-1
dbo:wikiPageID
  • 7085764 (xsd:integer)
dbo:wikiPageLength
  • 2323 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1010319668 (xsd:integer)
dbo:wikiPageWikiLink
dbp:casNumber
  • 209665 (xsd:integer)
dbp:class
dbp:component
  • Chlorproguanil (en)
  • Dapsone (en)
dbp:legalStatus
  • Withdrawn (en)
dbp:type
  • combo (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, which act synergystically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency. (en)
rdfs:label
  • Chlorproguanil/dapsone (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License